Skip to main content
. 2018 Mar 15;15(5):7751–7759. doi: 10.3892/ol.2018.8272

Figure 2.

Figure 2.

Kaplan-Meier analysis of survival differences in HCC patients. Difference of time to recurrence and overall survival for EBI3 in early-stage patients (A) and in all population (B). EBI3, Epstein-Barr virus-induced gene 3; HCC, hepatocellular carcinoma.